The aims of this study were to analyse the relationship between VHL genetic and epigenetic alterations, VHL expression and VEGF tumour or plasma expression, and to analyse their respective prognostic value in patients with CCRCC. This evidence concerns the gene VEGFA and nonpapillary renal cell carcinoma.